Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients aged \>=18 to \<65 years with a confirmed diagnosis of HIV receiving a stable regimen of ATRIPLA, COMPLERA, STRIBILD, TRIUMEQ, or any approved antiretroviral protease inhibitor such as atazanavir, darunavir, indinavir, ritonavir, and saquinavir in combination with (preferably) TRIUMEQ consistent with the most recent prescribing information documents for at least 6 weeks before concomitant administration of a single oral dose of 0.5 mg riociguat
No clinical evidence of pulmonary hypertension
Written informed consent
You may not be if
Severe diseases for which it can be assumed that the pharmacokinetics or effects of the study drug will not be normal
